Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | IDO1 | P14902 | 3/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5188628 | 0.88 | HTR2A (0.46) | TAAR1IDO1ALDH1A1PKMHTR2A | |
| SCHEMBL3306954 | 0.86 | HTR2A (0.56) | TAAR1SMN1; SMN2IDO1ALDH1A1HTR2A | |
| SCHEMBL27902405 | 0.83 | KEAP1 (0.64) | TAAR1IDO1GAANPSR1L3MBTL1 | |
| SCHEMBL9440186 | 0.83 | TAAR1 (0.43) | TAAR1IDO1HTR2AKEAP1MAOB | |
| SCHEMBL17644775 | 0.81 | MAOB (0.50) | TAAR1SMN1; SMN2IDO1MAOBMAPT | |
| Dimethylamine SCHEMBL27719549 | 0.80 | TAAR1 (0.53) | TAAR1SMN1; SMN2L3MBTL1ALDH1A1HTR2A | |
| SCHEMBL19143126 | 0.80 | LTA4H (0.46) | TAAR1ALDH1A1PKMKEAP1 | |
| SCHEMBL3301625 | 0.80 | TAAR1 (0.59) | TAAR1IDO1L3MBTL1ALDH1A1 | |
| SCHEMBL14415632 | 0.79 | HTR2A (0.71) | TAAR1SMN1; SMN2HTR2AMAOB | |
| SCHEMBL17644776 | 0.78 | SLC5A1 (0.48) | SMN1; SMN2L3MBTL1ALDH1A1PKMHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2702041-A1 | ALKALOID ESTER AND CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF | Chiesi Farmaceutici S.p.A. (IT) | 2014-03-05 | — | — | EP | disclosed |
| US-8604015-B2 | Alkaloid ester and carbamate derivatives and medicinal compositions thereof | CHIESI FARMACEUTICI S.P.A. (IT) | 2013-12-10 | — | — | US | disclosed |
| WO-2012146515-A1 | ALKALOID ESTER AND CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF | CHIESI FARMACEUTICI S.P.A. (IT) | 2012-11-01 | — | — | WO | disclosed |
| US-20120276018-A1 | ALKALOID ESTER AND CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF | CHIESI FARMACEUTICI S.P.A. (IT) | 2012-11-01 | — | — | US | disclosed |
| WO-2011126903-A2 | MULTISUBSTITUTED AROMATIC COMPOUNDS AS INHIBITORS OF THROMBIN | VERSEON, INC. (US) | 2011-10-13 | — | — | WO | disclosed |
| US-6242654-B1 | REACTING A PHENOLATE COMPOUND WITH AN ORGANIC FLUORINATING AGENT TO PREPARE A FLUORINE SUBSTITUTED AROMATIC COMPOUND | MITSUI CHEMICALS, INC. (JP) | 2001-06-05 | — | — | US | disclosed |
| EP-1013629-A1 | Preparation process of fluorine subsituted aromatic compound | Mitsui Chemicals, Inc. (JP) | 2000-06-28 | — | — | EP | disclosed |
| US-5256742-A | Preparation of poly(arylene sulfide)s from poly(arylene sulfide disulfide) | PHILLIPS PETROLEUM COMPANY (US) | 1993-10-26 | — | — | US | disclosed |
| EP-0194984-B1 | DERIVATIVES OF IMIDAZOLE, THEIR PREPARATION AND UTILISATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES | CONTINENTAL PHARMA, INC. (BE) | 1990-04-04 | — | — | EP | disclosed |
| EP-0044184-A2 | Blend of polyarylene sulfide and wholly aromatic polyester | CELANESE CORPORATION (US) | 1982-01-20 | — | — | EP | disclosed |
| US-4276397-A | IMPROVED PROCESSABILITY TO FORM MOLDED ARTICLES | CELANESE CORPORATION (US) | 1981-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120276018-A1 | ALKALOID ESTER AND CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF | CHRM3, BCHE, CHRM1 | TAAR1 977/4885SMN1; SMN2 3411/4885IDO1 1302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.